↓ Skip to main content

International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain

Overview of attention for article published in International Journal of Pharmaceutical Medicine, January 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
18 Mendeley
Title
International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain
Published in
International Journal of Pharmaceutical Medicine, January 2018
DOI 10.1007/s40290-018-0223-0
Pubmed ID
Authors

Azhar H. Alostad, Douglas T. Steinke, Ellen I. Schafheutle

Abstract

Herbal medicine (HM) regulation is less developed than that of allopathic medicines, with some countries lacking specific regulations. For the purpose of informing a registration system for HMs in Kuwait, which does not manufacture but imports all HMs, this study compared the similarities and differences between the current HM registration systems of five countries. The five countries were selected as major source countries of HM in Kuwait (United Kingdom (UK), Germany and United States of America (USA)) or because of geographical proximity or size and approach (United Arab Emirates (UAE) and Kingdom of Bahrain). Documentary analysis of HM classification systems was performed by reviewing the regulatory and law documentation of these countries' drug regulatory authority websites. Data on HM definition, classification and the main requirements for registration were extracted and analysed for similarities and differences. There was diversity in the classification of HMs across all five countries including terms used, definitions, type of law, requirements, restrictions and preparation type. The regulatory authorities of the UK, Germany, UAE  and Kingdom of Bahrain offer simplified registration for HMs, where plausible efficacy as a result of established traditional use is sufficient. In USA, the concept of traditional use does not exist, instead, the product can be categorised as a dietary supplement where no assessment or evaluation is required prior to marketing. Owing to the inconsistencies in how drug regulatory authorities define HMs, it will be important to design a clear definition of what constitutes a HM in Kuwait, which is a country that does not produce and register its own products but assesses products registered elsewhere.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 22%
Student > Ph. D. Student 3 17%
Unspecified 3 17%
Student > Bachelor 2 11%
Other 1 6%
Other 5 28%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 7 39%
Unspecified 3 17%
Biochemistry, Genetics and Molecular Biology 2 11%
Medicine and Dentistry 2 11%
Agricultural and Biological Sciences 2 11%
Other 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2018.
All research outputs
#3,702,356
of 12,817,668 outputs
Outputs from International Journal of Pharmaceutical Medicine
#14
of 65 outputs
Outputs of similar age
#118,157
of 343,813 outputs
Outputs of similar age from International Journal of Pharmaceutical Medicine
#1
of 1 outputs
Altmetric has tracked 12,817,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 65 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them